Beyond the Drip Podcast

Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. In this episode of Beyond the Drip, Jon Love and the crew sit down with returning guest Connie Sullivan, President & CEO of the National Home Infusion Association, for a grounded conversation on where the industry stands heading into 2026. From mounting pressure on drug pricing to the realities of Medicare coverage gaps, Connie breaks down the forces shaping access, reimbursement, and care delivery. The group also dives into the growing role of home infusion in rare disease treatment, what recent legislation does (and doesn’t) fix, and why providers still face complexity at every step of the revenue cycle. AI is everywhere—but where does it actually fit in infusion today? And what should providers be cautious about? If you’re trying to keep up with policy changes, payer dynamics, and the operational challenges behind the scenes, this episode brings clarity without the fluff. Key Takeaways: The growing impact of drug pricing pressure—and how it’s creating instability across access, quality, and reimbursement models Record attendance at NHIA’s conference and why this year’s sessions matter given rapid policy and regulatory changes What the Joe Fiandra Act actually does—and why it doesn’t fully expand access due to structural limitations (like the pump requirement) Why Medicare coverage remains a major barrier to home infusion, especially once patients turn 65 The shift toward treating rare diseases in the home—and how the industry has moved from debating safety to focusing on value and quality of life Why infusion revenue cycle is uniquely complex, with no standardized rules and heavy front-end dependency The role of advocacy: continuity across administrations, bipartisan support, and the growing influence of state-level action AI’s practical role today—best suited for repetitive tasks, with real opportunity in helping providers better communicate clinical impact The need to better articulate the value of pharmacists—not just tasks, but their direct impact on patient outcomes Rising scrutiny of payers, vertical integration, and lack of competition—and what that could mean for future reform

Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. As the year comes to a close, Beyond the Drip delivers a forward-looking conversation on the evolving infusion and specialty pharmacy landscape. In the final episode of the year, our co-hosts sit down with Vic Simianu, CEO and Founder of Sphinx Strategies, to discuss his path into infusion, the mounting pressures on independent pharmacies and what the next three to five years will require from industry leaders. With a background in biotech, finance and early-stage startups, Vic entered specialty pharmacy just as it was emerging as a $60 billion industry, which is now a trillion-dollar market. That experience shaped his decision to launch Sphinx Strategies, recognizing that independent pharmacies needed a way to stay competitive without billion-dollar budgets. Today, Sphinx helps pharmacies strengthen operations, data strategy and long-term growth in an increasingly complex market. Key Takeaways The infusion and specialty pharmacy market has rapidly evolved, increasing pressure on independent providers to adapt and differentiate. Clear value propositions and niche focus are essential as pharmacies face closures and tighter margins. Integrated operations, clinical expertise and data strategy are critical for long-term success and must be driven by leadership. Strong data and disease-state expertise improve access to manufacturers, especially as new cell and gene therapies come to market. Pharmacies should optimize and leverage existing data and workflows before expanding services or sites of care. Site-of-care strategies must align with patient volume, provider preferences and operational scale to be successful. At its core, this episode highlights a clear message: sustainable growth in infusion pharmacy comes from operational excellence, smart data strategy and focused differentiation. Vic explains that Sphinx Strategies partners with pharmacies to identify missing puzzle pieces, whether that’s strategy, valuation, due diligence or long-term planning, so they can stay competitive and build lasting ROI. Don’t miss this final Beyond the Drip episode of the year for a discussion on where infusion pharmacy is headed and how independent providers can position themselves for the future. Tune in now! ---Vic Simianu, Founder & CEO of Sphinx StrategiesVic Simianu is the Founder and CEO of Sphinx Strategies, a consulting group focused on building highly integrated specialty pharmacy operations. One of the industry’s earliest ACHC-Certified Specialty Pharmacy Consultants, Vic brings deep expertise in accreditation strategy, operational excellence, and oncology-focused specialty services. His experience spans independent pharmacies, large IDNs, ACOs, and publicly traded organizations. Vic holds an MBA from Indiana University Kelley School of Business and leads Sphinx Strategies from Boulder, Colorado.Beyond the Drip Co-hosts:Paula Roth, VP of Pharmacy Services at ProchantAs Vice President of Pharmacy Operations at Prochant, Paula leads an expert team focused on enhancing the home-based care industry through innovative technology and streamlined processes. With more than 20 years of experience in revenue cycle management for alternate sites of care, Paula leverages technology and teams to ensure clients achieve or exceed their financial targets.Jon Love, President & Chief Growth Officer at MedEdge Solutions Jon Love joins MedEdge with leadership experience in the infusion and specialty pharmacy industries. He has previously served in sales at WellSky, chief operating officer at Rock-Pond Solutions and senior VP of pharmacy services at Prochant.Pamela McIntyre, founder and owner of Expert Infusion Nurse Consulting With 40 years of experience in infusion nursing, Pam founded Expert Infusion Nurse Consulting to advance excellence in infusion and mentor other infusion professionals. Her certifications include CRNI, IgCN, OCN and VA-BC, and she has an immersive background in home infusion and ambulatory infusion in the fields of acute and chronic care, including oncology nursing. Brandon Carpenter, President of MedEdge Solutions Brandon Carpenter is the owner and founder of MedEdge Solutions. With more than 12 years of experience in pharmacy solutions, process improvement and data analytics, Brandon takes an active role in each of our projects. Prior to forming MedEdge, Brandon was the Director of Products and Professional Services at Rock-Pond Solutions where he worked with over 250 pharmacies nationwide to solve problems ranging from system integrations, financial reporting, 340B, Limited Drug Distribution, software management and more. He is a graduate of the University of Central Arkansas where he received his bachelor’s in business & information systems, as well as his Master of Business Administration. Brian O’Sullivan, President of The O’Sullivan Group Brian O’Sullivan formed The O’Sullivan Group, Inc. in February 1999 to serve health care providers with managed care and provider business development services. Over the years, The O’Sullivan Group has also been sought out by Medicare Advantage and Managed Medicaid plans to assist with network development needs. His vision for The O’Sullivan Group, Inc. was to bring real world know-how by offering the same level of service and expertise for both large and small companies that are enjoyed by major Fortune 1000 organizations.

Beyond the Drip: Elevating Ig Therapy Through Education and Standards Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. In episode 12 of Beyond the Drip, hosts Jon Love, Paula Roth, Brandon Carpenter, Pam McIntyre and Brian O’Sullivan welcome Luba Sobolevski, CEO and founder of IgNS, and Chief Clinical Officer Amy Clarke to discuss the evolving world of immunoglobulin (Ig) therapy and the 14th annual IgNS conference. The conversation highlights why IgNS was founded: to fill critical gaps in clinician education and standardize practices for a complex, lifelong therapy. Unlike fields such as oncology, Ig therapy historically offered limited training, leaving nurses and pharmacists underprepared to manage patient care and navigate regulatory and payer requirements. The IgNS conference, often called the “Super Bowl” of Ig therapy, brings together every sector of the industry from manufacturers and distributors to clinicians, pharmacists and infusion centers. Attendees can choose from business and clinical tracks, gaining guidance on revenue cycle management, documentation and legally defensible standards of practice. The discussion also explores how AI and technology are transforming care, from speech-to-text documentation and data analysis to wearable monitoring, while emphasizing that clinical judgment remains irreplaceable. Patient-focused initiatives, including education and surveys, ensure standards translate into safer, more effective care. Key Takeaways: Ig therapy is highly complex, with multiple indications, dosing protocols and routes of administration, creating unique challenges for clinicians and payers. Standardized education and competency frameworks help clinicians deliver safer, patient-centered care. The IgNS conference provides actionable guidance for clinical and revenue cycle professionals, including documentation, prior authorizations and payer collaboration. AI can streamline workflows and enhance decision-making but must be paired with expert clinical oversight. Patient education and feedback are essential to measure the impact of standards on care and outcomes. This episode offers insights into how IgNS is advancing Ig therapy standards, supporting clinicians and improving patient care. Listen to the full conversation on Beyond the Drip and subscribe to stay informed on the innovations shaping infusion care. Guest Speakers:Luba Sobolevsky, Pharm.D., IgCP®, President | CEO at Immunoglobulin National Society Dr. Luba Sobolevsky is the President and Chief Executive Officer of the Immunoglobulin National Society (IgNS), the central, standards-setting healthcare organization in the field of Ig therapy and biologics. Dr. Sobolevsky has over 25 years of diverse leadership experience across the healthcare field, including clinical practice, education, and pharmaceutical industry. She oversees IgNS’ strategic initiatives and the development of comprehensive programs and resources that promote best clinical practices and optimal patient outcomes. She is responsible for expanding and improving interdisciplinary and industry-wide collaboration and alliances.Dr. Sobolevsky leads IgNS’ Patient 360 division, dedicated to patient advocacy, education and outcomes research. She has been actively engaged in research and publication in areas of optimizing immunoglobulin practice, patient experience, health equity, healthcare team competencies, and the improvement of screening and diagnosis of rare diseases. Dr. Sobolevsky holds a PharmD degree from the University of Southern California and a BA from the University of California, Los Angeles. Amy E. Clarke, DNP RN IgCN®, Chief Clinical Officer at Immunoglobulin National Society Amy Clarke brings over 30 years of nursing experience, with a strong foundation in both clinical care and operational leadership. Her work has focused extensively on advancing immunoglobulin and infusion nursing practice, and she has had the opportunity to collaborate and present alongside respected colleagues at national and international conferences, including those hosted by NHIA, INS, ACAAI, and, of course, the Immunoglobulin National Society (IgNS).Dr. Clarke has contributed to the development of best practices in immunoglobulin therapy through co-authored publications and her involvement on several IgNS committees, including those responsible for the Ig Therapy Standards of Practice and the certification programs for nurses and pharmacists.Beyond the Drip Co-hosts:Paula Roth, VP of Pharmacy Services at ProchantAs Vice President of Pharmacy Operations at Prochant, Paula leads an expert team focused on enhancing the home-based care industry through innovative technology and streamlined processes. With more than 20 years of experience in revenue cycle management for alternate sites of care, Paula leverages technology and teams to ensure clients achieve or exceed their financial targets.Jon Love, President & Chief Growth Officer at MedEdge Solutions Jon Love joins MedEdge with leadership experience in the infusion and specialty pharmacy industries. He has previously served in sales at WellSky, chief operating officer at Rock-Pond Solutions and senior VP of pharmacy services at Prochant.Pamela McIntyre, founder and owner of Expert Infusion Nurse Consulting With 40 years of experience in infusion nursing, Pam founded Expert Infusion Nurse Consulting to advance excellence in infusion and mentor other infusion professionals. Her certifications include CRNI, IgCN, OCN and VA-BC, and she has an immersive background in home infusion and ambulatory infusion in the fields of acute and chronic care, including oncology nursing. Brandon Carpenter, President of MedEdge Solutions Brandon Carpenter is the owner and founder of MedEdge Solutions. With more than 12 years of experience in pharmacy solutions, process improvement and data analytics, Brandon takes an active role in each of our projects. Prior to forming MedEdge, Brandon was the Director of Products and Professional Services at Rock-Pond Solutions where he worked with over 250 pharmacies nationwide to solve problems ranging from system integrations, financial reporting, 340B, Limited Drug Distribution, software management and more. He is a graduate of the University of Central Arkansas where he received his bachelor’s in business & information systems, as well as his Master of Business Administration. Brian O’Sullivan, President of The O’Sullivan Group Brian O’Sullivan formed The O’Sullivan Group, Inc. in February 1999 to serve health care providers with managed care and provider business development services. Over the years, The O’Sullivan Group has also been sought out by Medicare Advantage and Managed Medicaid plans to assist with network development needs. His vision for The O’Sullivan Group, Inc. was to bring real world know-how by offering the same level of service and expertise for both large and small companies that are enjoyed by major Fortune 1000 organizations.

Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. In this episode, the hosts explore a topic that’s becoming impossible to ignore across the infusion therapy landscape: the escalating talent crisis. Host Jon Love noticed that, while many anticipated themes emerged at NHIA, one issue seemed to rise above the rest - finding and keeping skilled professionals in infusion pharmacy. This episode dives deep into the roots of the problem, examining the shrinking pipeline of pharmacy professionals, increasing burnout and the complexity of the infusion model that demands both clinical and technical excellence. From the unique challenges of revenue cycle management to the alarming decline in pharmacy school enrollment, the conversation is a wake-up call for infusion providers and a call to action. The discussion also highlights how organizations must balance human expertise with smart technology. While automation and AI can alleviate some of the burden, certain roles, especially clinical ones, simply cannot be replaced. The key, according to the hosts, lies in building intentional systems, investing in talent and preparing for a future where skilled infusion professionals are in short supply. Key Takeaways: Infusion pharmacy roles require both clinical knowledge and operational expertise, highlighting the need for cross-trained professionals in a highly specialized field. Limited exposure to infusion in pharmacy education, coupled with declining pharmacy school enrollment, is shrinking the pipeline of qualified professionals. High burnout rates and increasing turnover among experienced staff are intensifying staffing challenges and compromising care delivery. Understanding the unique revenue cycle demands of infusion—such as payer rules and drug billing—is essential for financial sustainability and growth. Strategic use of automation can relieve staffing pressure, but success depends on integrating technology with expert oversight and structured workflows. The talent crisis isn’t going away anytime soon, but this episode of Beyond the Drip offers a roadmap for navigating it. Whether you’re a pharmacy leader, clinician or revenue cycle manager, the insights shared here can help you reframe the problem, refocus your strategy and reinvest in the people who power your infusion business. Hear the full conversation on Beyond the Drip to explore how leaders are tackling the infusion talent crisis and what steps you can take to build a stronger, more resilient team. Listen now and subscribe to stay informed on the innovations transforming infusion care. Beyond the Drip Co-hosts:Paula Roth, VP of Pharmacy Services at ProchantAs Vice President of Pharmacy Operations at Prochant, Paula leads an expert team focused on enhancing the home-based care industry through innovative technology and streamlined processes. With more than 20 years of experience in revenue cycle management for alternate sites of care, Paula leverages technology and teams to ensure clients achieve or exceed their financial targets.Jon Love, President & Chief Growth Officer at MedEdge Solutions Jon Love joins MedEdge with leadership experience in the infusion and specialty pharmacy industries. He has previously served in sales at WellSky, chief operating officer at Rock-Pond Solutions and senior VP of pharmacy services at Prochant.Pamela McIntyre, founder and owner of Expert Infusion Nurse Consulting With 40 years of experience in infusion nursing, Pam founded Expert Infusion Nurse Consulting to advance excellence in infusion and mentor other infusion professionals. Her certifications include CRNI, IgCN, OCN and VA-BC, and she has an immersive background in home infusion and ambulatory infusion in the fields of acute and chronic care, including oncology nursing. Brandon Carpenter, President of MedEdge Solutions Brandon Carpenter is the owner and founder of MedEdge Solutions. With more than 12 years of experience in pharmacy solutions, process improvement and data analytics, Brandon takes an active role in each of our projects. Prior to forming MedEdge, Brandon was the Director of Products and Professional Services at Rock-Pond Solutions where he worked with over 250 pharmacies nationwide to solve problems ranging from system integrations, financial reporting, 340B, Limited Drug Distribution, software management and more. He is a graduate of the University of Central Arkansas where he received his bachelor’s in business & information systems, as well as his Master of Business Administration. Brian O’Sullivan, President of The O’Sullivan Group Brian O’Sullivan formed The O’Sullivan Group, Inc. in February 1999 to serve health care providers with managed care and provider business development services. Over the years, The O’Sullivan Group has also been sought out by Medicare Advantage and Managed Medicaid plans to assist with network development needs. His vision for The O’Sullivan Group, Inc. was to bring real world know-how by offering the same level of service and expertise for both large and small companies that are enjoyed by major Fortune 1000 organizations.

Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. As we step into 2025, the latest episode of Beyond the Drip sets the stage for a year filled with both opportunities and challenges in the infusion and pharmacy space. The hosts reflect on the key events of 2024 that shaped the industry, including major disruptions like the Change Healthcare cyberattack, supply chain issues and regulatory shifts. They also explore the pressing topics that will define 2025, such as drug pricing, revenue cycle management (RCM) hurdles and the expanding role of artificial intelligence (AI) in healthcare. Key Takeaways: Looking Back at 2024 The Change Healthcare cyberattack disrupted revenue cycles and patient care, with some providers still recovering. Supply chain disparities, highlighted by issues in North Carolina’s manufacturing plants, revealed inequities in home-based care access. Healthcare consolidation and private equity influence remain hot topics, with concerns about fair treatment in regulatory decisions. The industry showcased resilience despite these setbacks, adapting to rapid changes. What’s Ahead in 2025? Biologic products are growing rapidly, creating challenges in training staff and ensuring proper reimbursement. Providers struggle with securing payment for high-cost drugs due to unclear payor guidelines. The new administration’s approach to healthcare policy remains unpredictable. While AI has immense potential in RCM, patient safety risks must be considered, particularly with AI-driven data repositories becoming prime hacking targets. The hosts emphasize the importance of consistently tracking industry news to stay ahead of evolving regulations and trends. The Beyond the Drip team encourages providers to proactively address these issues by diversifying vendors, investing in proper training and carefully evaluating AI applications. With so much in flux, adaptability and informed decision-making will be key drivers of success in 2025. Stay tuned for more episodes as we continue to explore the shifting landscape of infusion and specialty pharmacy. Beyond the Drip Co-hosts:Paula Roth, VP of Pharmacy Services at ProchantAs Vice President of Pharmacy Operations at Prochant, Paula leads an expert team focused on enhancing the home-based care industry through innovative technology and streamlined processes. With more than 20 years of experience in revenue cycle management for alternate sites of care, Paula leverages technology and teams to ensure clients achieve or exceed their financial targets.Jon Love, President & Chief Growth Officer at MedEdge Solutions Jon Love joins MedEdge with leadership experience in the infusion and specialty pharmacy industries. He has previously served in sales at WellSky, chief operating officer at Rock-Pond Solutions and senior VP of pharmacy services at Prochant.Pamela McIntyre, founder and owner of Expert Infusion Nurse ConsultingWith 40 years of experience in infusion nursing, Pam founded Expert Infusion Nurse Consulting to advance excellence in infusion and mentor other infusion professionals. Her certifications include CRNI, IgCN, OCN and VA-BC, and she has an immersive background in home infusion and ambulatory infusion in the fields of acute and chronic care, including oncology nursing. Brandon Carpenter, President of MedEdge SolutionsBrandon Carpenter is the owner and founder of MedEdge Solutions. With more than 12 years of experience in pharmacy solutions, process improvement and data analytics, Brandon takes an active role in each of our projects. Prior to forming MedEdge, Brandon was the Director of Products and Professional Services at Rock-Pond Solutions where he worked with over 250 pharmacies nationwide to solve problems ranging from system integrations, financial reporting, 340B, Limited Drug Distribution, software management and more. He is a graduate of the University of Central Arkansas where he received his bachelor’s in business & information systems, as well as his Master of Business Administration. Brian O’Sullivan, President of The O’Sullivan GroupBrian O’Sullivan formed The O’Sullivan Group, Inc. in February 1999 to serve health care providers with managed care and provider business development services. Over the years, The O’Sullivan Group has also been sought out by Medicare Advantage and Managed Medicaid plans to assist with network development needs. His vision for The O’Sullivan Group, Inc. was to bring real world know-how by offering the same level of service and expertise for both large and small companies that are enjoyed by major Fortune 1000 organizations.

Welcome to “Beyond the Drip,” where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. In a pivotal episode of Beyond the Drip this Thanksgiving week, the hosts unpack the ripple effects of CVS Health's decision to exit the infusion market, a move that impacts nearly half a million patients and reshapes the industry. This conversation shines a light on the opportunities and challenges for small and mid-cap home infusion providers in a rapidly evolving landscape. With a focus on scaling complexities, the critical role of local dynamics and the importance of patient care, the episode explores how smaller, community-focused providers can step into the gaps left by larger players. The speakers also discuss key industry trends, including supply chain issues, the indispensable role of nursing and the need for advocacy to support small providers. As the healthcare landscape shifts, this episode offers valuable insights for infusion and pharmacy providers looking to navigate change and thrive in a service-oriented industry. Key takeaways include: Success in the infusion market relies on understanding and leveraging local payer dynamics, regulations, and community engagement. Scaling is often challenging in the infusion market due to local variations, requiring tailored approaches rather than one-size-fits-all solutions. Community-focused providers can capitalize on the gaps left by larger players, using local knowledge and relationships to grow and expand. Smaller providers face significant challenges securing necessary goods, highlighting the need for strategic planning. Providers must align high-quality patient care with financial sustainability to succeed. The infusion business thrives on personalized, high-touch service that prioritizes patient outcomes. To conclude, the discussion shifts to the future of home infusion care, addressing how local dynamics and personalized service can help smaller providers gain an edge. By focusing on their unique strengths, these organizations can adapt to industry changes and meet evolving patient needs.Beyond the Drip Co-hosts:Jon Love, VP of Pharmaceutical Services at Prochant Jon Love joined Prochant in 2020 and was previously director of sales for WellSky’s home care division and COO for Rock Pond Solutions, a software provider for home infusion, HME and specialty pharmacies.Pamela McIntyre, founder and owner of Expert Infusion Nurse ConsultingWith 40 years of experience in infusion nursing, Pam founded Expert Infusion Nurse Consulting to advance excellence in infusion and mentor other infusion professionals. Her certifications include CRNI, IgCN, OCN and VA-BC, and she has an immersive background in home infusion and ambulatory infusion in the fields of acute and chronic care, including oncology nursing. Brandon Carpenter, President of MedEdge SolutionsBrandon Carpenter is the owner and founder of MedEdge Solutions. With more than 12 years of experience in pharmacy solutions, process improvement and data analytics, Brandon takes an active role in each of our projects. Prior to forming MedEdge, Brandon was the Director of Products and Professional Services at Rock-Pond Solutions where he worked with over 250 pharmacies nationwide to solve problems ranging from system integrations, financial reporting, 340B, Limited Drug Distribution, software management and more. He is a graduate of the University of Central Arkansas where he received his bachelor’s in business & information systems, as well as his Master of Business Administration. Brian O’Sullivan, President of The O’Sullivan Group Brian O’Sullivan formed The O’Sullivan Group, Inc. in February 1999 to serve health care providers with managed care and provider business development services. Over the years, The O’Sullivan Group has also been sought out by Medicare Advantage and Managed Medicaid plans to assist with network development needs. His vision for The O’Sullivan Group, Inc. was to bring real world know-how by offering the same level of service and expertise for both large and small companies that are enjoyed by major Fortune 1000 organizations.

Welcome to “Beyond the Drip,” where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. In episode four, we have a special guest, Randy Broyles, Chief Strategy Officer at CSI Pharmacy. An in-depth exploration of the career and insights of Randy Broyles in the Infusion industry. A history of navigating growth, challenges and M&A activity and what we can learn form it for the future.

In this episode of Beyond the Drip, the hosts discuss the Wild West of infusion therapy. They explore the reasons behind the growth of infusion therapy, including the consumer-centric approach and the demand for quality healthcare. They also discuss the challenges and risks involved in entering the infusion therapy market, such as the lack of common language and the need for expertise. The hosts highlight the importance of understanding the payer landscape and the operational hurdles of staffing, logistics, and training. They also touch on the influx of private equity and independent pharmacies into the market. The conversation explores the challenges and opportunities in the infusion therapy industry, particularly in the emerging field of ambulatory infusion centers (AICs). The speakers discuss the shortage of IV fluids due to non-medical use, the merging of the infusion world, and the need for proper training and patient safety in IV bars. They also touch on the importance of compliance and regulation, cautionary tales of failed AICs, and the future of the industry, including consolidation and the potential for new entrants.Keywordsinfusion therapy, Wild West, growth, consumer-centric, challenges, risks, payer landscape, operational hurdles, staffing, logistics, training, private equity, independent pharmacies, infusion therapy, ambulatory infusion centers, IV fluids, IV bars, training, patient safety, compliance, regulation, cautionary tales, consolidation, new entrantsTakeawaysInfusion therapy is experiencing significant growth due to its consumer-centric approach and the demand for quality healthcare.Entering the infusion therapy market comes with challenges and risks, including the lack of a common language and the need for expertise.Understanding the payer landscape is crucial for success in the infusion therapy market.Operational hurdles such as staffing, logistics, and training are important considerations for infusion therapy centers.The market is seeing an influx of private equity and independent pharmacies, which adds to the competition and complexity of the industry. There is a shortage of IV fluids due to non-medical use, which is affecting the availability of products for medically ill patients.The infusion world is merging, with more IV bars potentially transitioning to treat medically ill patients.Proper training and understanding of patient care in the infusion therapy industry is crucial, as the process of placing an IV and administering medications is different for medically ill patients.There have been cases of unlicensed personnel treating patients in IV clinics and med spas, leading to serious complications and even deaths.The industry needs to focus on patient safety, education, and compliance to prevent harm and maintain quality outcomes.Payers should prioritize standards that address quality outcomes and staff training in AICs, rather than solely accrediting the pharmacy function.Opening an AIC requires careful consideration of referral plans, payer strategies, and contracts to ensure financial viability and success.Consolidation in the infusion therapy industry, similar to what happened in home infusion, may occur in the future.The future of the industry may involve healthcare organizations offering a range of infusion services, including home infusion, specialty infusion, AICs, and AISs.The success of AICs lies in high service, high touch, patient-centric care, and convenience.TitlesUnderstanding the Payer Landscape in Infusion TherapyNavigating the Uncharted Territory of Infusion Therapy Cautionary Tales and Lessons Learned in the AIC SpaceThe Merging World of Infusion Therapy and the Rise of AICsSound Bites"I saw enough.""Beyond the Drip is a comprehensive podcast around the infusion providers, infusion therapies and everything.""This episode is called the Wild West of Infusion.""There is a shortage on IV fluids. There's a nationwide problem getting products for people who are sick because of the non-medical use.""I'm worried about consumers who have that low expectation of quality that any nurse can stick a needle in their arm and give them B12 or whatever it is.""Did you know as long as the medical director is within their confines, a physician can supervise anyone to administer IVs?"Chapters00:00The Wild West of Infusion06:26Uncharted Territory09:19High Potential Rewards10:47Significant Risks15:59The Importance of Experts and a Common Language17:17Understanding the Payer Landscape17:43Considering the Competitive Landscape18:13The Wild West of Infusion Therapy23:09Training and Compliance: Ensuring Patient Safety28:12Patient Safety and the Potential Risks33:20Consolidation: The Future of the Industry36:53Success Stories and Cautionary Tales42:18The Future of Infusion Therapy: Risks and Opportunities